The efficacy and safety of Metoprolol in preventing cardiomyopathy in patients with Duchenne Muscular Dystrophy
What is metoprolol? Could it help in developing new method of treatment for patients suffering from cardiomiopathy associated with the Duchenne Muscular Dystrophy (DMD), a rare and serious genetic disorder characterised by progressive muscle degeneration and weakness?
Learn of the project conducted by Magdalena Bazgier M.D. and her team of fellow researchers led by Joanna Kwiatkowska, Ph.D., D.Sc. and see why it might bring an important breakthrough in the fight against the disease.
Magdalena Bazgier, M.D.
Ph.D. student and a doctor of medicine (graduated 2020) conducting her research in the field of, among others, paediatric cardiology. Awarded at the 15th Warsaw International Medical Congress (2019) and Juvenes Pro Medicina (2020) as the co-author of prestigious publications.